tristearin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bersani, S; Bertucco, A; Caliceti, P; Elvassore, N; Salmaso, S | 1 |
| Bertucco, A; Caliceti, P; Elvassore, N; Salmaso, S | 1 |
2 other study(ies) available for tristearin and Alloxan Diabetes
| Article | Year |
|---|---|
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
Topics: Animals; Biological Availability; Blood Glucose; Body Weight; Carbon Dioxide; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Female; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Time Factors; Triglycerides | 2009 |
Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process.
Topics: Animals; Blood Glucose; Carbon Dioxide; Chemistry, Pharmaceutical; Chromatography, Supercritical Fluid; Diabetes Mellitus, Experimental; Dimethyl Sulfoxide; Dioctyl Sulfosuccinic Acid; Drug Carriers; Drug Compounding; Drug Stability; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Kinetics; Lipids; Male; Mice; Mice, Inbred BALB C; Nebulizers and Vaporizers; Particle Size; Phosphatidylcholines; Polyethylene Glycols; Polysorbates; Powders; Protein Denaturation; Protein Stability; Solubility; Technology, Pharmaceutical; Triglycerides | 2009 |